339 related articles for article (PubMed ID: 25308528)
41. Vitiligo Pathogenesis and Emerging Treatments.
Rashighi M; Harris JE
Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
[TBL] [Abstract][Full Text] [Related]
42. New perspectives on the role of vitiligo in immune responses to melanoma.
Byrne KT; Turk MJ
Oncotarget; 2011 Sep; 2(9):684-94. PubMed ID: 21911918
[TBL] [Abstract][Full Text] [Related]
43. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB
J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528
[TBL] [Abstract][Full Text] [Related]
44. Vitiligo: Mechanistic insights lead to novel treatments.
Frisoli ML; Harris JE
J Allergy Clin Immunol; 2017 Sep; 140(3):654-662. PubMed ID: 28778794
[TBL] [Abstract][Full Text] [Related]
45. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
[TBL] [Abstract][Full Text] [Related]
46. Engineered antigen-specific regulatory T cells for autoimmune skin conditions.
Mukhatayev Z; Ostapchuk YO; Fang D; Le Poole IC
Autoimmun Rev; 2021 Mar; 20(3):102761. PubMed ID: 33476816
[TBL] [Abstract][Full Text] [Related]
47. Regulatory T Cells in Hepatic Immune Tolerance and Autoimmune Liver Diseases.
Herkel J
Dig Dis; 2015; 33 Suppl 2():70-4. PubMed ID: 26642346
[TBL] [Abstract][Full Text] [Related]
48. Decreased
Giri PS; Bharti AH; Dwivedi M
J Immunol Res; 2022; 2022():3426717. PubMed ID: 36157881
[TBL] [Abstract][Full Text] [Related]
49. The Immunogenetics of Vitiligo: An Approach Toward Revealing the Secret of Depigmentation.
Dwivedi M; Laddha NC; Begum R
Adv Exp Med Biol; 2022; 1367():61-103. PubMed ID: 35286692
[TBL] [Abstract][Full Text] [Related]
50. Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo.
Liu XM; Zhou Q; Xu SZ; Wakamatsu K; Lei TC
Free Radic Biol Med; 2011 May; 50(9):1177-85. PubMed ID: 21256957
[TBL] [Abstract][Full Text] [Related]
51. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected?
Namazi MR
Pigment Cell Res; 2007 Oct; 20(5):360-3. PubMed ID: 17850509
[TBL] [Abstract][Full Text] [Related]
52. Levels of TGF-β(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo.
Tu CX; Jin WW; Lin M; Wang ZH; Man MQ
Arch Dermatol Res; 2011 Nov; 303(9):685-9. PubMed ID: 21644048
[TBL] [Abstract][Full Text] [Related]
53. Vitiligo.
Kovacs SO
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):647-66; quiz 667-8. PubMed ID: 9591808
[TBL] [Abstract][Full Text] [Related]
54. Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity.
Dwivedi M; Kumar P; Laddha NC; Kemp EH
Autoimmun Rev; 2016 Apr; 15(4):379-92. PubMed ID: 26774011
[TBL] [Abstract][Full Text] [Related]
55. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
56. Vitiligo therapy: restoring immune privilege?
Boniface K; Seneschal J; Taïeb A; Merched A
Exp Dermatol; 2017 Jul; 26(7):635-636. PubMed ID: 27314920
[TBL] [Abstract][Full Text] [Related]
57. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
Boniface K; Seneschal J; Picardo M; Taïeb A
Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
[TBL] [Abstract][Full Text] [Related]
58. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
59. Vitiligo puzzle: the pieces fall in place.
Westerhof W; d'Ischia M
Pigment Cell Res; 2007 Oct; 20(5):345-59. PubMed ID: 17850508
[TBL] [Abstract][Full Text] [Related]
60. Regulatory T cells in autoimmune skin diseases.
Ujiie H
Exp Dermatol; 2019 Jun; 28(6):642-646. PubMed ID: 29575350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
